儿科病房对超说明书药物的不良反应:意大利前瞻性试点研究

P. Impicciatore, A. Mohn, F. Chiarelli, C. Pandolfini, M. Bonati
{"title":"儿科病房对超说明书药物的不良反应:意大利前瞻性试点研究","authors":"P. Impicciatore, A. Mohn, F. Chiarelli, C. Pandolfini, M. Bonati","doi":"10.1185/146300902322125118","DOIUrl":null,"url":null,"abstract":"Recently published studies examining the extent of off-label drug prescribing in various European paediatric wards have reported that off-label use is widespread and particularly high in Italy. So far, however, no studies have investigated the extent to which adverse drug reactions (ADRs) due to off-label drug use occur in Italy. To evaluate the risk associated with off-label drug use in paediatric inpatients, a prospective surveillance study was carried out in the paediatric ward of a teaching hospital over a 9 month period. Forty-one children (mean age: 7.2 years, 58% male ), out of a study population of 1619 patients, experienced ADRs. In 29 children the ADRs were due to in hospital drug therapies, while in 12 they were due to medicines administered in the community. Urticaria (11 cases), vomiting and rash (5 cases each ) and tremor (4 cases) were the most common ADRs. Eight ADRs (20%) were classified as severe. The drugs most frequently associated with ADRs were salbutamol (5 cases) and coamoxiclav (4 cases). Off-label drug prescriptions were responsible for 38% of inpatient ADRs and for 42% of the ADRs occurring in the community that led to hospitalisation. The use of drugs not licensed for paediatric use (8 cases) or for indications for which the drug was not licensed (6 cases) were the off-label categories most frequently associated with ADRs. Drugs used for diagnostic tests in endocrinology were responsible for one third of ADRs due to off-label uses. The results of this study suggest a high risk of ADRs associated with offlabel prescribing in children, both in the hospital and in the community. This pilot study also demonstrates the feasibility of an ADR monitoring system that could take into account important issues relating to rational drug prescribing in paediatric patients. In order to achieve a comprehensive risk assessment of off-label drug interventions in children, the study should be continued and expanded to involve the community setting as well.","PeriodicalId":87451,"journal":{"name":"Paediatric and perinatal drug therapy","volume":"5 1","pages":"19-24"},"PeriodicalIF":0.0000,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"20","resultStr":"{\"title\":\"Adverse Drug Reactions to Off-label Drugs on a Paediatric Ward: an Italian Prospective Pilot Study\",\"authors\":\"P. Impicciatore, A. Mohn, F. Chiarelli, C. Pandolfini, M. Bonati\",\"doi\":\"10.1185/146300902322125118\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recently published studies examining the extent of off-label drug prescribing in various European paediatric wards have reported that off-label use is widespread and particularly high in Italy. So far, however, no studies have investigated the extent to which adverse drug reactions (ADRs) due to off-label drug use occur in Italy. To evaluate the risk associated with off-label drug use in paediatric inpatients, a prospective surveillance study was carried out in the paediatric ward of a teaching hospital over a 9 month period. Forty-one children (mean age: 7.2 years, 58% male ), out of a study population of 1619 patients, experienced ADRs. In 29 children the ADRs were due to in hospital drug therapies, while in 12 they were due to medicines administered in the community. Urticaria (11 cases), vomiting and rash (5 cases each ) and tremor (4 cases) were the most common ADRs. Eight ADRs (20%) were classified as severe. The drugs most frequently associated with ADRs were salbutamol (5 cases) and coamoxiclav (4 cases). Off-label drug prescriptions were responsible for 38% of inpatient ADRs and for 42% of the ADRs occurring in the community that led to hospitalisation. The use of drugs not licensed for paediatric use (8 cases) or for indications for which the drug was not licensed (6 cases) were the off-label categories most frequently associated with ADRs. Drugs used for diagnostic tests in endocrinology were responsible for one third of ADRs due to off-label uses. The results of this study suggest a high risk of ADRs associated with offlabel prescribing in children, both in the hospital and in the community. This pilot study also demonstrates the feasibility of an ADR monitoring system that could take into account important issues relating to rational drug prescribing in paediatric patients. In order to achieve a comprehensive risk assessment of off-label drug interventions in children, the study should be continued and expanded to involve the community setting as well.\",\"PeriodicalId\":87451,\"journal\":{\"name\":\"Paediatric and perinatal drug therapy\",\"volume\":\"5 1\",\"pages\":\"19-24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Paediatric and perinatal drug therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1185/146300902322125118\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatric and perinatal drug therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1185/146300902322125118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

摘要

最近发表的研究调查了欧洲各儿科病房超说明书用药的程度,报告称,超说明书用药很普遍,在意大利尤其严重。然而,到目前为止,还没有研究调查意大利因超说明书用药而发生的药物不良反应(adr)的程度。为了评估儿科住院患者超说明书用药的相关风险,在一家教学医院的儿科病房进行了为期9个月的前瞻性监测研究。在1619例研究人群中,41名儿童(平均年龄:7.2岁,58%为男性)出现了不良反应。在29名儿童中,不良反应是由医院药物治疗引起的,而在12名儿童中,不良反应是由社区给药引起的。最常见的不良反应为荨麻疹(11例)、呕吐、皮疹(各5例)和震颤(4例)。严重不良反应8例(20%)。最常发生不良反应的药物是沙丁胺醇(5例)和复方莫昔拉夫(4例)。说明书外药物处方导致38%的住院不良反应,42%的社区不良反应导致住院。使用未获许可的儿科药物(8例)或药物未获许可的适应症(6例)是最常与adr相关的标签外类别。用于内分泌学诊断测试的药物造成了三分之一的不良反应,这是由于标签外使用造成的。这项研究的结果表明,无论是在医院还是在社区,儿童的超说明书处方都有很高的不良反应风险。这项试点研究还证明了不良反应监测系统的可行性,该系统可以考虑到与儿科患者合理用药有关的重要问题。为了实现对儿童超说明书药物干预的全面风险评估,这项研究应该继续并扩大到社区环境。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Adverse Drug Reactions to Off-label Drugs on a Paediatric Ward: an Italian Prospective Pilot Study
Recently published studies examining the extent of off-label drug prescribing in various European paediatric wards have reported that off-label use is widespread and particularly high in Italy. So far, however, no studies have investigated the extent to which adverse drug reactions (ADRs) due to off-label drug use occur in Italy. To evaluate the risk associated with off-label drug use in paediatric inpatients, a prospective surveillance study was carried out in the paediatric ward of a teaching hospital over a 9 month period. Forty-one children (mean age: 7.2 years, 58% male ), out of a study population of 1619 patients, experienced ADRs. In 29 children the ADRs were due to in hospital drug therapies, while in 12 they were due to medicines administered in the community. Urticaria (11 cases), vomiting and rash (5 cases each ) and tremor (4 cases) were the most common ADRs. Eight ADRs (20%) were classified as severe. The drugs most frequently associated with ADRs were salbutamol (5 cases) and coamoxiclav (4 cases). Off-label drug prescriptions were responsible for 38% of inpatient ADRs and for 42% of the ADRs occurring in the community that led to hospitalisation. The use of drugs not licensed for paediatric use (8 cases) or for indications for which the drug was not licensed (6 cases) were the off-label categories most frequently associated with ADRs. Drugs used for diagnostic tests in endocrinology were responsible for one third of ADRs due to off-label uses. The results of this study suggest a high risk of ADRs associated with offlabel prescribing in children, both in the hospital and in the community. This pilot study also demonstrates the feasibility of an ADR monitoring system that could take into account important issues relating to rational drug prescribing in paediatric patients. In order to achieve a comprehensive risk assessment of off-label drug interventions in children, the study should be continued and expanded to involve the community setting as well.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Paediatric infliximab therapy: Patients' and parents' perspectives on treatment options Improving research and access to children's medicines worldwide Working with the pharmaceutical industry in relation to paediatric clinical trials. A British perspective How long does it take to administer oral medicines to children Paediatric asthma severity score and length of stay in patients presenting to a paediatric emergency department
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1